Literature DB >> 4262216

High molecular weight derivatives of human fibrinogen produced by plasmin. 3. Their NH2-terminal amino acids and comparison with the "NH2-terminal disulfide knot".

V J Marder, A Z Budzyński, H L James.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4262216

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  8 in total

1.  [The mechanism of blood cell sedimentation. XVIII. Sedimentation effect of fibrinogen plasminolysis products].

Authors:  H Hörmann
Journal:  Blut       Date:  1975-01

2.  Studies on the structural abnormality of fibrinogen Paris I.

Authors:  M W Mosesson; D L Amrani; D Ménaché
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

3.  The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".

Authors:  M W Mosesson; K R Siebenlist; J f Hainfeld; J S Wall; J Soria; C Soria; J P Caen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

4.  Discriminating neoantigenic differences between fibrinogen and fibrin derivatives.

Authors:  E F Plow; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

5.  The number of D and E regions in the fibrinogen molecule.

Authors:  E F Plow; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

6.  Location of peptide fragments in the fibrinogen molecule by immunoelectron microscopy.

Authors:  J N Telford; J A Nagy; P A Hatcher; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

7.  Characterization of the inhibition of fibrin assembly by fibrinogen fragment D.

Authors:  J E Williams; R R Hantgan; J Hermans; J McDonagh
Journal:  Biochem J       Date:  1981-09-01       Impact factor: 3.857

8.  "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.

Authors:  M Matsuda; M Baba; K Morimoto; C Nakamikawa
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.